Intraoperative Hyperglycemia and Infections After Orthopedic Surgery
NCT ID: NCT03903354
Last Updated: 2019-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2018-01-13
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Severe Intraoperative Hyperglycemia During Craniotomy and Postoperative Infections
NCT02165748
Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
NCT04285359
Hyperglycemia in Neurosurgery
NCT05236751
Blood Glucose Concentration & Craniotomy
NCT01923571
Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients
NCT01548963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incidence of infections within 7 days postoperatively
Measure blood glucose concentration intraoperatively and evaluate incidence of infections 7 days after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico Bilotta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federico Bilotta
Clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sapienza
Roma, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Federico Bilotta, M.D., Ph.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hypergly&Infect Orth patient
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.